A detailed history of Flagship Wealth Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Flagship Wealth Advisors, LLC holds 235 shares of MRNA stock, worth $5,818. This represents 0.0% of its overall portfolio holdings.

Number of Shares
235
Previous 160 46.88%
Holding current value
$5,818
Previous $4.41 Million 37.52%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 30, 2025

BUY
$23.51 - $34.67 $1,763 - $2,600
75 Added 46.88%
235 $6.07 Million
Q4 2024

Feb 10, 2025

BUY
$36.85 - $63.93 $5,896 - $10,228
160 New
160 $6.65 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.69B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Flagship Wealth Advisors, LLC Portfolio

Follow Flagship Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Wealth Advisors, LLC with notifications on news.